{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/284897137"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "the risk that we, our contract manufacturers or any of our third-party suppliers may encounter problems or delays in manufacturing or assembling drug products, drug product substances, capillary aerosolization devices and related components and other materials on a timely basis or in an amount sufficient to support our development efforts and, if our products are approved, commercialization;" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "financialcontent.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/412385553"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/284897137"] } } }
